DrugPatentWatch Database Preview
Drugs in Development Information for Pyrrole-2-Carboxylate
» See Plans and Pricing
What is the drug development status for Pyrrole-2-Carboxylate?
Pyrrole-2-Carboxylate is an investigational drug.
There have been 5 clinical trials for Pyrrole-2-Carboxylate.
The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2020.
The most common disease conditions in clinical trials are Pre-Eclampsia, Melanoma, and Venous Thrombosis. The leading clinical trial sponsors are Merck Sharp & Dohme Corp., Assiut University, and Second Affiliated Hospital, School of Medicine, Zhejiang University.
There are five hundred and ninety-nine US patents protecting this investigational drug and four international patents.
Summary for Pyrrole-2-Carboxylate
| US Patents | 599 |
| International Patents | 4,189 |
| US Patent Applications | 552 |
| WIPO Patent Applications | 1,171 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2020-03-01) |
| Vendors | 117 |
Recent Clinical Trials for Pyrrole-2-Carboxylate
| Title | Sponsor | Phase |
|---|---|---|
| Effect of Rosuvastatin on the Clinical Features of Preeclampsia | Assiut University | Phase 2 |
| Prophylactic Anticoagulation for Catheter-related Thrombosis | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 4 |
| Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer | Jiangsu HengRui Medicine Co., Ltd. | Phase 1/Phase 2 |
Clinical Trial Summary for Pyrrole-2-Carboxylate
Top disease conditions for Pyrrole-2-Carboxylate
Top clinical trial sponsors for Pyrrole-2-Carboxylate
US Patents for Pyrrole-2-Carboxylate
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Pyrrole-2-Carboxylate | Start Trial | Method of using aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds in the treatment of interleukin-1 mediated conditions | Merrell Dow Pharmaceuticals Inc. (Cincinnati, OH) | Start Trial |
| Pyrrole-2-Carboxylate | Start Trial | Novel aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions | Merrell Dow Pharmaceuticals Inc. (Cincinnati, OH) | Start Trial |
| Pyrrole-2-Carboxylate | Start Trial | 1-heterocyclic bicyclo-octanes | The Wellcome Foundation Limited (London, GB2) | Start Trial |
| Pyrrole-2-Carboxylate | Start Trial | Certain phosphonic acids and derivatives useful for the treatment of disorders responsive to N-methyl-D-aspartate receptor blockade | Ciba-Geigy Corporation (Ardsley, NY) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Pyrrole-2-Carboxylate
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Pyrrole-2-Carboxylate | Australia | 4875690 | 2009-01-31 | Start Trial |
| Pyrrole-2-Carboxylate | Australia | 625688 | 2009-01-31 | Start Trial |
| Pyrrole-2-Carboxylate | European Patent Office | 0381142 | 2009-01-31 | Start Trial |
| Pyrrole-2-Carboxylate | Japan | H02235814 | 2009-01-31 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
